Key statistics
On Thursday, Can Fite Biopharma Ltd (CANF:ASQ) closed at 2.05, 13.26% above the 52 week low of 1.81 set on Oct 27, 2023.
52-week range
Open | 2.08 |
---|---|
High | 2.08 |
Low | 1.95 |
Bid | 1.98 |
Offer | 2.24 |
Previous close | 2.03 |
Average volume | 173.46k |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Sep 26 2024 23:30 BST.
More ▼
Announcements
- Projected Income of $325M to Can-Fite Over the Next 10 Years After Vetbiolix Exercised its Option and Licensed Piclidenoson for Veterinary Osteoarthritis
- Can-Fite: Pancreatic Carcinoma Phase IIa Clinical Study with Namodenoson Received Regulatory Authorization from the Israeli Ministry of Health
- Can-Fite Announces Exercise of Warrants for Approximately $5.0 Million in Gross Proceeds
- Can-Fite Provides Namodenoson Patent Update
- Join Can-Fite’s Exclusive Live Investor Webinar and Q&A Session on August 8
- Can-Fite Applies for FDA Orphan Drug Designation for Namodenoson in the Treatment of Pancreatic Cancer
- Improvement in Patient with Decompensated Liver Cirrhosis Upon Treatment with Namodenoson
- Can-Fite Announces Exercise of Warrants for Approximately $3.0 Million in Gross Proceeds
More ▼